Back to Browse Journals » International Journal of Nanomedicine » Volume 5

Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes

Authors Alessandro Ruggiero, Carlos H Villa, Jason P Holland, et al

Published 30 September 2010 Volume 2010:5 Pages 783—802


Review by Single-blind

Peer reviewer comments 5

Alessandro Ruggiero1*, Carlos H Villa1*, Jason P Holland1, Shanna R Sprinkle1, Chad May2, Jason S Lewis1, David A Scheinberg1, Michael R McDevitt1
1Departments of Medicine and Radiology, Pharmacology and Molecular Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, USA; 2ImClone Systems, New York, USA; *Ruggiero and Villa contributed equally to this work

Abstract: Single wall carbon nanotube (SWCNT) constructs were covalently appended with radiometal-ion chelates (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid [DOTA] or desferrioxamine B [DFO]) and the tumor neovascular-targeting antibody E4G10. The E4G10 antibody specifically targeted the monomeric vascular endothelial-cadherin (VE-cad) epitope expressed in the tumor angiogenic vessels. The construct specific activity and blood compartment clearance kinetics were significantly improved relative to corresponding antibody-alone constructs. We performed targeted radioimmunotherapy with a SWCNT-([225Ac]DOTA)(E4G10) construct directed at the tumor vasculature in a murine xenograft model of human colon adenocarcinoma (LS174T). The specific construct reduced tumor volume and improved median survival relative to controls. We also performed positron emission tomographic (PET) radioimmunoimaging of the tumor vessels with a SWCNT-([89Zr]DFO)(E4G10) construct in the same murine LS174T xenograft model and compared the results to appropriate controls. Dynamic and longitudinal PET imaging of LS174T tumor-bearing mice demonstrated rapid blood clearance (<1 hour) and specific tumor accumulation of the specific construct. Incorporation of the SWCNT scaffold into the construct design permitted us to amplify the specific activity to improve the signal-to-noise ratio without detrimentally impacting the immunoreactivity of the targeting antibody moiety. Furthermore, we were able to exploit the SWCNT pharmacokinetic (PK) profile to favorably alter the blood clearance and provide an advantage for rapid imaging. Near-infrared three-dimensional fluorescent-mediated tomography was used to image the LS174T tumor model, collect antibody-alone PK data, and calculate the number of copies of VE-cad epitope per cell. All of these studies were performed as a single administration of construct and were found to be safe and well tolerated by the murine model. These data have implications that support further imaging and radiotherapy studies using a SWCNT-based platform and focusing on the tumor vessels as the target.

Keywords: actinium-225 (225Ac), zirconium-89 (89Zr), angiogenesis, vascular endothelial-cadherin, radioimmunotherapy (RIT), radioimmunoPET

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma

Wei MY, Guo XC, Tu LX, Zou Q, Li Q, Tang CY, Chen B, Xu YH, Wu CB

International Journal of Nanomedicine 2015, 10:5123-5137

Published Date: 12 August 2015

Stress, anxiety, and depression among medical students in a multiethnic setting

Kulsoom B, Afsar NA

Neuropsychiatric Disease and Treatment 2015, 11:1713-1722

Published Date: 16 July 2015

A histological evaluation and in vivo assessment of intratumoral near infrared photothermal nanotherapy-induced tumor regression

Green HN, Crockett SD, Martyshkin DV, Singh KP, Grizzle WE, Rosenthal EL, Mirov SB

International Journal of Nanomedicine 2014, 9:5093-5102

Published Date: 5 November 2014

Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats

Anandamoy Rudra, R Manasa Deepa, Miltu Kumar Ghosh, et al

International Journal of Nanomedicine 2010, 5:811-823

Published Date: 11 October 2010

Synthesis and characterization of silver/talc nanocomposites using the wet chemical reduction method

Kamyar Shameli, Mansor Bin Ahmad, Wan Zin Wan Yunus, et al

International Journal of Nanomedicine 2010, 5:743-751

Published Date: 29 September 2010

Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model

Muthu Irulappan Sriram, Selvaraj Barath Mani Kanth, Kalimuthu Kalishwaralal, et al

International Journal of Nanomedicine 2010, 5:753-762

Published Date: 24 September 2010

Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes

Yingna He, Linhua Zhang, Cunxian Song

International Journal of Nanomedicine 2010, 5:697-705

Published Date: 20 September 2010

Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles

Dongmei Zhao, Xiuhua Zhao, Yuangang Zu, et al

International Journal of Nanomedicine 2010, 5:669-677

Published Date: 13 September 2010

Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging

Adrian Chrastina, Jan E Schnitzer

International Journal of Nanomedicine 2010, 5:653-659

Published Date: 1 September 2010

Biomimetic nanoparticles: preparation, characterization and biomedical applications

Ana Maria Carmona-Ribeiro

International Journal of Nanomedicine 2010, 5:249-259

Published Date: 1 April 2010